Overall, the enhanced fluorescence is associated with low expression of ferrochelatase, overexpression of ABCB6, low expression of ABCG2, the accumulation of heme synthesis-related metabolites caused by IDH1 mutations, and the tumor microenvironment. The gene discussed is ABCB6; the disease is neoplasm.